Skip to main content
OpenTrials

Clinical trial condition

Advanced Cancer

Explore clinical trials studying Advanced Cancer. Study availability and eligibility vary by location and protocol.

455 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Advanced Cancer trial results

Active, Not Recruiting

Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer

NCT02112188

Conditions
Advanced Cancer
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

NCT05782361

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • DDU, Royal Marsden Hospital NHS Foundation Trust Sutton, Surrey, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
  • Lung Unit, Royal Marsden Hospital NHS Foundation Trust London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532

Conditions
Advanced Cancer, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
  • National Cancer Center Hospital Chūōku, Japan
View Trial Details

Related conditions